Liquid Biopsy Month
In this month of international lung cancer awareness, Diaceutics would like to shed light on the remarkable impact of diagnostic testing on the cancer patient journey. One of the pivotal advancements in this field is the progressive use of liquid biopsy (LBx), a non-invasive and innovative method that has revolutionised precision medicine diagnostics.
1st November - 30 November 2023
In recognition of the transformative power of liquid biopsy in precision medicine diagnostics, we are excited to announce the launch of Diaceutics LBx Month. This initiative is designed to complement Lung Cancer Awareness Month and raise awareness about the importance of diagnostic testing in cancer care. Throughout this month, we will host a range of events, webinars, and educational sessions to highlight the advancements in liquid biopsy technology and its role in improving patient outcomes.
Sign up and be the first to hear of our LBx content releases and events through the month of November!
Diaceutics Liquid Biopsy Month
Other liquid biopsy events hosted by Diaceutics through the month of November include:
Wednesday 8th November 2023
Liquid biopsy in oncohematology: Ready for clinic?
Join us for an illuminating webinar featuring two distinguished experts in the field of oncohematology as they delve into the cutting-edge realm of liquid biopsies, their pivotal role in the detection of minimal residual disease (MRD) and investigate their role in the diagnostics of aggressive B cell lymphoma and multiple myeloma.
Sign up to access the recording
Thursday 16th November 2023:
The Liquid Biopsy Series: Detection of molecular residual disease in circulating DNA
The final instalment of the Liquid Biopsy LabTalk series will focus on MRD and LBx, where the promising data obtained for colorectal and non-small cell lung cancer will also be presented and discussed.
Sign up to access the recording
Wednesday 30th November 2023:
Revolutionizing Solid Tumor Management: Unleashing the Potential of Liquid Biopsy
Join our exclusive webinar, "Revolutionizing Solid Tumor Management: Unleashing the Potential of Liquid Biopsy ," for a comprehensive exploration of the groundbreaking world of liquid biopsy in cancer diagnosis and treatment. This session is your opportunity to delve into the key aspects of liquid genomic profiling and its implications for both pathologists and oncologists.